Undersea & Hyperbaric Medicine Journal Volume 45, Issue #1

Course overview

As a result of having attended the meeting, the participants should have had the opportunity to: 1) To understand the components of the Framingham Risk Score; 2) To be able to discuss the impact that the ADCI’s recommendation to screen all commercial divers over the age 35 with the FRS may have; 3) To understand one way to adopt this change to benefit both divers and management; 4) To understand how hyperbaric oxygen can reverse retinal ischemia in an eye even when the central retinal artery has become obstructed; 5) Be familiar with the recommended follow-up management of an eye that has been successfully treated with hyperbaric oxygen for central retinal artery occlusion during the initial HBO2 session; 6) Understand the possible uses of the data available in the Hyperbaric Oxygen Therapy Registry; 7) Understand the role of the Qualified Clinical data Registry (QCDR) for physicians subject to the Merit Based Incentive Payment System (MIPS). Subject Matter: Adjunctive hyperbaric oxygen treatment for idiopathic sudden sensorineural hearing loss: Research Article; Do not fear the Framingham: Practical application to properly evaluate and modify cardiovascular risk in commercial divers; Case Report Management of central retinal artery occlusion following successful hyperbaric oxygen therapy; Technical Communication; The Hyperbaric Oxygen Therapy Registry: Driving quality and demonstrating compliance. Teaching Methods: Journal Reading, Examination of material, Evaluation of activity. Evaluation Methods: Evaluation is offered through the online educational portal with 3 graded questions each UHM Journal paper and an overall evaluation at the completion of the Journal-based activity. Referenes: 1. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005; 140: 376-391. 2. Duker JS, Brown GC. Recovery following acute obstruction of the retinal and choroidal circulations. Retina. 1988; 8: 257-260. 3. Hadanny A, Maliar A, Fishlev G, Bechor Y, Bergan J, Friedman M, Avni I, Efrati S. Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen. Clinical Ophthalmology. 2017; 11:115-125. 4. Murphy-Lavoie H, Butler F, Hagan C. Arterial insuffciencies: central retinal artery occlusion. In: Weaver LK, editor. Undersea and Hyperbaric Medical Society Hyperbaric Oxygen Therapy Indications. 13th ed. The Hyperbaric Oxygen Therapy Committee Report, North Palm Beach, Florida: Best Publishing; 2014. 5. Butler FK, Hagan C, Murphy-Lavoie H. Hyperbaric oxygen therapy and the eye. Undersea Hyperb Med. 2008; 35: 333-387. 6. Murphy-Lavoie H, Butler FK, Hagan CE: Central retinal artery occlusion treated with oxygen: a literature review and treatment algorithm. Undersea Hyperb Med. 2012; 39: 943-953 7. Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol. 2001;11: 345-350. 8. Phillips D, Diaz C, Atwell G, Chimiak J, Ullman S, et al. Care of sudden blindness: A case report of acute central retinal artery occlusion reversed with hyperbaric oxygen therapy. Undersea Hyperb Med. 1999; 26 (supp):23-24. (abstract) 9. Li HK, Dejean BJ, Tang RA. Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac Syndrome. Ophthalmology. 1996; 103: 2091-2098. 10. Yotsukura J, Adachi-Usami E. Correlation of electroretinographic changes with visual prognosis in central retinal artery occlusion. Ophthalmologica. 1993; 207:13-18. 11. Beiran I, Reissman P, Scharf J, Nahum Z, Miller B. Hyperbaric oxygenation combined with nifedipine treatment for recent-onset retinal artery occlusion. Eur J Ophthalmol. 1993; 3: 89-94. 12. Hertzog LM, Meyer GW, Carson S, Strauss MB, Hart GB. Central retinal artery occlusion treated with hyperbaric oxygen. J Hyperbaric Medicine. 1992; 7: 33-42. 13. Landers MB. Retinal oxygenation via the choroidal circulation. Trans Am Ophthalmol Soc. 1978; 76: 528-556. 14. Patz A.